These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8112969)

  • 1. Intravitreal penetration of oral pefloxacin in humans.
    Oncel M; Peyman GA
    Int Ophthalmol; 1993 Aug; 17(4):217-22. PubMed ID: 8112969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM; Mieler WF; Holz ER
    Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
    Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA
    Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans.
    Lesk MR; Ammann H; Marcil G; Vinet B; Lamer L; Sebag M
    Am J Ophthalmol; 1993 May; 115(5):623-8. PubMed ID: 8488915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
    Hariprasad SM; Mieler WF; Holz ER
    Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration.
    Sakamoto H; Sakamoto M; Hata Y; Kubota T; Ishibashi T
    Eur J Ophthalmol; 2007; 17(3):372-6. PubMed ID: 17534819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous and Aqueous Penetration of Orally Administered Trimethoprim-Sulfamethoxazole Combination in Humans.
    Feiz V; Nijm L; Glickman RD; Morse LS; Telander DG; Park SS; Polage CR; Christiansen SM; Moshirfar M
    Cornea; 2013 Oct; 32(10):1315-20. PubMed ID: 23928948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and tolerability of intravitreal pefloxacin in rabbits.
    Cochereau-Massin I; Marrakchi-Benjaafar S; Bauchet J; Vallois JM; Faurisson F; D'Hermies F; Pocidalo JJ
    J Antimicrob Chemother; 1994 Feb; 33(2):231-42. PubMed ID: 8182004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
    Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
    Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Hariprasad SM; Shah GK; Mieler WF; Feiner L; Blinder KJ; Holekamp NM; Gao H; Prince RA
    Arch Ophthalmol; 2006 Feb; 124(2):178-82. PubMed ID: 16476886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
    Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
    Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
    Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
    Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous penetration of orally administered famciclovir.
    Chong DY; Johnson MW; Huynh TH; Hall EF; Comer GM; Fish DN
    Am J Ophthalmol; 2009 Jul; 148(1):38-42.e1. PubMed ID: 19375688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous and vitreous penetration of levofloxacin after oral administration.
    Fiscella RG; Nguyen TK; Cwik MJ; Phillpotts BA; Friedlander SM; Alter DC; Shapiro MJ; Blair NP; Gieser JP
    Ophthalmology; 1999 Dec; 106(12):2286-90. PubMed ID: 10599658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal penetration of cefepime after systemic administration to humans.
    Aras C; Ozdamar A; Ozturk R; Karacorlu M; Ozkan S
    Ophthalmologica; 2002; 216(4):261-4. PubMed ID: 12207129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man].
    Salvanet-Bouccara A; Montay G; Fisch A; Forestier F; Meziane D; Lafaix C; Prieur MB
    J Fr Ophtalmol; 1991; 14(4):260-4. PubMed ID: 1955654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ocular penetration of oral sparfloxacin in humans.
    Bron AM; Pechinot AP; Garcher CP; Guyonnet GA; Kazmierczak AM; Schott DA; Lecoeur H
    Am J Ophthalmol; 1994 Mar; 117(3):322-7. PubMed ID: 8129004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
    Vemulakonda GA; Hariprasad SM; Mieler WF; Prince RA; Shah GK; Van Gelder RN
    Arch Ophthalmol; 2008 Jan; 126(1):18-22. PubMed ID: 18195213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.